Shufeng Jiedu capsule for acute exacerbation of chronic obstructive pulmonary disease: a protocol of multicentre, randomised, double-blind, placebo-controlled trial

Introduction Chronic obstructive pulmonary disease (COPD) represents one of the leading causes of death worldwide. Published clinical trials suggest that the Chinese patent herbal medicine Shufeng Jiedu capsule (SFJD) is safe and may be effective for treating acute exacerbations of COPD (AECOPD). Ho...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Michael Moore, Ruyu Xia, Xiaoyang Hu, Merlin Willcox, Jianping Liu, Yutong Fei, Nick Francis, Mengyuan Dai, Lishan Zhang, Zhijun Jie, Xiaoyun Fan, Changhao Liang, Guanghe Fei
Format:	Artigo
Sprog:	Inglês
Udgivet:	BMJ Publishing Group 2023-09-01
Serier:	BMJ Open
Online adgang:	https://bmjopen.bmj.com/content/13/9/e070864.full
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!